The company operates movie multiplexes and an OTT streaming platform called WOWPLEX, and is currently diversifying into solar power generation and petroleum product distribution.
The company lacks a sustainable competitive advantage, evidenced by negative average ROCE and ROE. While it claims a unique position in content creation, its tiny revenue base and pivot into unrelated industries like solar and petroleum suggest a lack of core business durability.
Management has shifted capital from the core multiplex business into a wholly-owned tech subsidiary and is now proposing entry into capital-intensive, unrelated sectors like solar parks and fuel distribution. This scattergun approach lacks strategic coherence and has yet to generate meaningful returns.
The company's scattergun diversification into solar and petroleum proved to be a value-destroying distraction from its failing multiplex core. Capital was incinerated in these high-intensity sectors where the firm had zero expertise, while the lack of internal controls and oversight led to a slow leak of resources through related-party transactions. The promotional narrative regarding OTT and tech never translated into cash flow, leaving the business as a hollow shell of unrelated assets with no operational synergy or earnings power.
RichFakir rates City Pulse Multiventures Ltd's business quality as poor — 33/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, City Pulse Multiventures Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on City Pulse Multiventures Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of City Pulse Multiventures Ltd's fair value is about ₹5 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →